In the Vietnamese CRC cohort, 58% of patients harbored at least one matched neoantigen, with mutation frequency strongly correlating with predicted HLA presentation, particularly for HLA-A alleles. The gene discussed is HLA-A; the disease is colorectal carcinoma.